Tarsus Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100001448294

Total reported 2019–2025

$15.8M

#378 of 2,960 reporting companies — 0% of all reported industry payments

$11.7M in general payments across 82,653 records, plus $4.12M in research funding across 183 records.

How it breaks down

General payments $11,672,122

Research funding $4,124,058

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.